Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell.

Hematopoiesis was investigated in a 14-yr-old girl who had a 2-yr history of stable asymptomatic pancytopenia and who was also heterozygous at the structural locus for glucose-6-phosphate dehydrogenase (G-6-PD). There was no morphologic or cytogenetic evidence for preleukemia and no suggestion of Fanconi anemia. In the skin and sheep erythrocytes-rosetted T lymphocytes, the ratio of G-6-PD A/B activities was 1:1. However, only type B activity was found in peripheral blood erythrocytes, granulocytes, and platelets. Most erythroid bursts and all granulocyte/macrophage colonies formed in methylcellulose culture were derived from the abnormal clone. These findings demonstrate that (a) some cases of pancytopenia are stem cell diseases that apparently develop clonally; (b) circulating differentiated cells originate from this clone; (c) despite a hypoproliferative anemia, the in vivo expression of presumably normal (nonclonal) progenitors is suppressed. In this patient, the relationship between clonal dominance and possible malignancy may be assessed prospectively.

[1]  S. Zolla-Pazner,et al.  Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma. , 1982, The American journal of medicine.

[2]  D. Parkinson,et al.  Regulation of human blood erythroid burst-forming unit (BFU-E) proliferation by T-lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. , 1982, Blood.

[3]  J. Adamson,et al.  Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. , 1981, Blood.

[4]  J. Adamson,et al.  Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy. , 1981, The Journal of clinical investigation.

[5]  R. Chaganti,et al.  Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. , 1981, Pediatrics.

[6]  E. Cronkite,et al.  Radioimmunoassay of erythropoietin: circulating levels in normal and polycythemic human beings. , 1980, The Journal of laboratory and clinical medicine.

[7]  H. Haak,et al.  In vitro tests for distinguishing possible immune-mediated aplastic anemia from transfusion-induced sensitization. , 1980, Blood.

[8]  I. Magrath,et al.  Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. , 1979, The New England journal of medicine.

[9]  G. Stamatoyannopoulos,et al.  F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. , 1975, Blood.

[10]  G. Stamatoyannopoulos,et al.  A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait. , 1975, Blood.

[11]  P. Fialkow.  Primordial cell pool size and lineage relationships of five human cell types* , 1973, Annals of human genetics.

[12]  Linman Jw,et al.  Studies on the diagnostic significance of hemoglobin F levels. , 1973, Mayo Clinic proceedings.

[13]  S. Gartler,et al.  Clonal origin of chronic myelocytic leukemia in man. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Clark,et al.  Human T Lymphocyte Cell Surface Molecules Defined by the Workshop Monoclonal Antibodies (“T Cell Protocol”) , 1984 .

[15]  J. Adamson,et al.  Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. , 1981, Blood.

[16]  P. Fialkow.  Clonal and Stem Cell Origin of Blood Cell Neoplasms , 1980 .

[17]  J. Singer,et al.  Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro. , 1979, Blood.

[18]  W. Rosse.  Paroxysmal nocturnal haemoglobinuria in aplastic anaemia. , 1978, Clinics in haematology.

[19]  R. Sparkes,et al.  Cellulose acetate electrophoresis of human glucose-6-phosphate dehydrogenase. , 1969, The Journal of laboratory and clinical medicine.